VentriPoint Diagnostics Ltd.

PNK:VPTDF

$0.0897 USD

$0.0 (5.41%)

Volume
5K
Average Volume
33.46K
Market Capitalization
$14.53M
P/E Ratio
-3.44
Dividend Yield
0.00%
Price Target
$
Year High
$0.27
Year Low
$0.09
Payout Ratio
$0.00
Current Ratio
$0.28

Industry, Sector & symbol

Stock Exchange Other OTC
CEO Mr. Hugh MacNaught
Industry Medical - Devices
Sector Healthcare
Current Symbol VPTDF
CUSIP None
CIK None
Web https://www.ventripoint.com
Phone None
Currency USD
Employees None
Country CA

Liquidity

Debt-to-Equity Ratio -0.47
Payout Ratio 0.00
Current Ratio 0.28
Quick Ratio 0.28
Cash Ratio 0.19

Sales & Book Value

Annual Sales $49183
Price / Sales 237.41
Cash Flow -0.03
Price / Cash Flow -4.35
Price / Book -8.43

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0311
Trailing P/E Ratio -3.44
PEG Ratio 0.55
P/E Growth 0.55
Net Income $-4.87M
Net Margin -6966.13%
Pretax Margin -6966.13%
Return on Equity 1364.98%
Return on Assets -748.72%

Financials Score

AltmanZ Score -140.35
Piotroski Score 3.00
Working Capital -1.15M
Total Assets 670.52K
Ebit -4.97M
Market Cap 14.53M
Total Liabilities 2.72M

Poll Results

About VentriPoint Diagnostics Ltd. (PNK:VPTDF) Stock

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart is ... sues. The company was incorporated in 2004 and is based in Toronto, Canada.

Frequently Asked Questions

What is the current VentriPoint Diagnostics Ltd. (VPTDF) stock price?

VentriPoint Diagnostics Ltd.(PNK:VPTDF) stock price is $0.0897 in the last trading session. During the trading session, VPTDF stock reached the peak price of $0.2687 while $0.0858 was the lowest point it dropped to. The percentage change in VPTDF stock occurred in the recent session was 5.41% while the dollar amount for the price change in VPTDF stock was $0.0.

VPTDF's industry and sector of operation?

The PNK listed VPTDF is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of VPTDF?

Matt Dobson | Marketing Director
Mr. Hugh MacNaught | Interim Chief Executive Officer, President & Director
Mr. Jim Graba | Application Specialist & Chief Trainer
Mr. Jimmy Jeon | Chief Financial Officer
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. | Executive Chairman & Corporate Secretary

How many employees does VPTDF have?

Number of VPTDF employees currently stands at None. VPTDF operates from 18 Hook Avenue, Toronto, ON M6P 1T4, CA.

Link for VPTDF official website?

Official Website of VPTDF is: https://www.ventripoint.com

How do I contact VPTDF?

VPTDF could be contacted at phone #None and can also be accessed through its website. VPTDF operates from 18 Hook Avenue, Toronto, ON M6P 1T4, CA.

How many shares of VPTDF are traded daily?

The average number of VPTDF shares traded daily for last 3 months was 33.46K.

What is the market cap of VPTDF currently?

The market value of VPTDF currently stands at $14.53M with its latest stock price at $0.0897